Any current/future new fundraising through debt or equity?

The transcript from the document does not mention any plans for current or future fundraising through debt or equity. The company is focused on capacity expansion, particularly in grain-based ethanol and bio-based chemicals, but specific financing details are not discussed. Capital expenditure guidance includes an estimated INR 325 crores capex by FY29, with 75% allocated to bio-based chemicals and 25% to ethanol, implying internal funding or existing resources are being utilized. No explicit mention of raising fresh equity or taking on new debt is made during the call. The company emphasizes

Any current/future capex/capital investment/strategic investment?

Godavari Biorefineries is investing in capacity expansion, notably: - Adding a grain-based (maize) ethanol distillery facility, with commissioning expected next quarter due to some equipment delays. - Continuing investments in bio-based specialty chemicals capacity through debottlenecking and expansions. Total planned capex is estimated at INR 325 crores by FY29, with approximately 75% allocated to bio-based chemicals and 25% to ethanol. Strategic investments include: - Licensing deal with Catalyxx for bio-based butanol production. - Collaboration with Synthomer to commercialize bio-ba

Future growth expectations in sales/revenue/volumes?

Godavari Biorefineries expects robust growth through capacity expansions, especially in grain/maize-based ethanol distilleries. The company targets a significant increase in revenue, aiming for close to INR 3,000 crores topline by 2029 with 10-11% EBITDA margin. Expansion of bio-based chemicals, including specialty chemicals and bio-based monomers, is a key driver for high-margin growth. Increasing ethanol blending mandates (E20 achieved 5 years ahead of schedule) and potential introduction of flex fuel vehicles will boost ethanol demand. Continuous innovation and co-creation with customers to

Future growth expectations in earnings/operating earnings/profits/EPS?

Godavari Biorefineries aims to achieve a 3x EBITDA growth by FY29, targeting INR 3000 crores topline with 10-11% EBITDA margin (Page 13). The company is optimistic about long-term growth driven by green transition, ethanol blending (E20 achieved 5 years ahead of schedule), and expanding bio-based chemicals (Pages 14-16). Capacity expansion in grain-based ethanol distillery expected to improve utilization from next quarter onwards (Pages 7, 13). Focus on portfolio diversification and new bio-based specialty chemicals to drive better margins and capacity utilization (Pages 12-14). Continued cost

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders for Godavari Biorefineries Limited. The company has received binding supply obligations for ethanol volumes through OMC tenders for the ethanol supply year. Operational and financial preparations are underway to service these mandated volumes despite margin pressures from rising cane costs. The grain-based ethanol facility commissioning is delayed but expected by next quarter, which will support their capacity to meet orders. The company is focusing on adding capacity and debottlenecking in bio-base

IN US

Sale is live|00:00:00left today

Godavari Biorefineries LtdQ4 FY27Diversified FMCG

Godavari Biorefineries Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹287P/E: 29.7Market Cap: ₹1.6K CrSector: Diversified FMCG

Management growth scorecard

Revenue

Category 3

Margin

Category 1

Fundraise

N/A

Order

N/A

Capex

Yes

2 of 3 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→Godavari Biorefineries expects robust growth through capacity expansions, especially in grain/maize-based ethanol distilleries.
→The company targets a significant increase in revenue, aiming for close to INR 3,000 crores topline by 2029 with 10-11% EBITDA margin.
→Expansion of bio-based chemicals, including specialty chemicals and bio-based monomers, is a key driver for high-margin growth.
→Increasing ethanol blending mandates (E20 achieved 5 years ahead of schedule) and potential introduction of flex fuel vehicles will boost ethanol demand.
→Continuous innovation and co-creation with customers to develop green transition products underpin growth.
→Consumer brand Jivana has crossed INR 100 crores sales in 9 months and is expected to broaden distribution and product portfolio.
→The company plans disciplined execution, capital efficiency, and portfolio optimization for sustainable long-term value creation.

Margin guidance

Category 1

→Godavari Biorefineries aims to achieve a 3x EBITDA growth by FY29, targeting INR 3000 crores topline with 10-11% EBITDA margin (Page 13).
→The company is optimistic about long-term growth driven by green transition, ethanol blending (E20 achieved 5 years ahead of schedule), and expanding bio-based chemicals (Pages 14-16).
→Capacity expansion in grain-based ethanol distillery expected to improve utilization from next quarter onwards (Pages 7, 13).
→Focus on portfolio diversification and new bio-based specialty chemicals to drive better margins and capacity utilization (Pages 12-14).
→Continued cost optimization, improved product mix, and operating leverage led to a 13.8% EBITDA growth in Q3 FY26, with margins improving by 97 bps to 9.8% (Page 3).
→Company maintains a bullish stance on the sector for medium to long term, emphasizing capital efficiency and innovation (Pages 2-4).

3 more insights locked — sign up free to unlock

Fundraise plans

→The transcript from the document does not mention any plans for current or future fundraising through debt or equity.
→The company is focused on capacity expansion, particularly in grain-based ethanol and bio-based chemicals, but specific financing details are not discussed.
→Capital expenditure guidance includes an estimated INR 325 crores capex by FY29, with 75% allocated to bio-based chemicals and 25% to ethanol, implying internal funding or existing resources are being utilized.
→No explicit mention of raising fresh equity or taking on new debt is made during the call.
→The company emphasizes cash flow discipline and managing working capital but without concrete plans for external fundraising stated.

Order book

→The transcript does not explicitly mention the current or expected order book or pending orders for Godavari Biorefineries Limited.
→The company has received binding supply obligations for ethanol volumes through OMC tenders for the ethanol supply year.
→Operational and financial preparations are underway to service these mandated volumes despite margin pressures from rising cane costs.
→The grain-based ethanol facility commissioning is delayed but expected by next quarter, which will support their capacity to meet orders.
→The company is focusing on adding capacity and debottlenecking in bio-based chemicals and ethanol to support growth.
→There is an active strategy to co-create specialized bio-based chemicals with customers, involving signed MOUs (e.g., with Synthomer for bio-based butanol), indicating ongoing and potential future orders in specialty chemicals.
→Overall, no specific numeric order book or pending orders data is disclosed.

Capex plans

Yes

→Godavari Biorefineries is investing in capacity expansion, notably:
→ - Adding a grain-based (maize) ethanol distillery facility, with commissioning expected next quarter due to some equipment delays.
→ - Continuing investments in bio-based specialty chemicals capacity through debottlenecking and expansions.
→Total planned capex is estimated at INR 325 crores by FY29, with approximately 75% allocated to bio-based chemicals and 25% to ethanol.
→Strategic investments include:
→ - Licensing deal with Catalyxx for bio-based butanol production.
→ - Collaboration with Synthomer to commercialize bio-based butyl acrylate.
→ - Pilot plant development for dimethyl ether (DME) technology in partnership with the Institute of Chemical Technology.
→ - Research into cancer biology molecules and bio-based chemical products as part of ongoing innovation pipelines.
→Focus on balancing capital allocation to ensure predictable earnings and managing feedstock and regulatory risks through multi-feedstock distilleries.

How does Godavari Biorefineries Ltd rank vs peers in Diversified FMCG?

Pro feature

1Godavari Biorefineries Ltd

Rev 3Mar 1

See full Diversified FMCG sector rankings

Want more stocks like Godavari Biorefineries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio